AbstractIn this study, the serological status of the southern Greek population in the 1–10-year, 11–20-year, 21–30-year and 31–40-year age groups with regard to Sabin vaccine strains and a collection of 15 recombinant and four non-recombinant poliovirus vaccine strains was determined. For all three poliovirus types, the highest neutralization test (NT) titres were observed in the 1–10-year age group, indicating a good response to vaccination. In general, the serological status of the population of southern Greece with regard to poliovirus is better for types 1 and 2 than for type 3. The presence of the lowest NT titre in the 21–30-year age group against poliovirus type 3 suggests the need for a booster dose of monovalent Sabin3 vaccine to e...
BACKGROUND: In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by rout...
Introduction. Italy and Europe were declared polio-free in June 2002, but increasing migration, even...
Abstract Introduction The extensive use of oral and inactivated poliovirus (PV) vaccines has driven ...
P>In this study, the serological status of the southern Greek population in the 1-10-year, 11-20-yea...
AbstractThe live oral poliovirus vaccine (OPV) strains are genetically unstable, causing, in rare ca...
The live oral poliovirus vaccine (OPV) strains are genetically unstable, causing, in rare cases, vac...
ABSTRACTThis study assessed immunity to poliomyelitis in a representative sample of 1064 persons liv...
During clinical trials, samples from Hungarian patients of different age groups were tested for anti...
The immune status against polioviruses was investigated in a population of 545 students aged 11-20 y...
In this study, the immunity level of the southern Greek population in the 1-10-year, 11-20-year, 21-...
Background: In October 2007, the working group CEN/TC 216 of the European Committee for standardisat...
The widespread use of poliovirus vaccination schemes has led to a marked decline in the incidence of...
The WHO European Region has been declared polio-free since 2002. By 2010, inactivated polio vaccine ...
Background and aim of the work: Recent seroprevalence studies in different population groups have ...
In 2002, the WHO European Region was declared polio-free. Nonetheless global eradication has not yet...
BACKGROUND: In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by rout...
Introduction. Italy and Europe were declared polio-free in June 2002, but increasing migration, even...
Abstract Introduction The extensive use of oral and inactivated poliovirus (PV) vaccines has driven ...
P>In this study, the serological status of the southern Greek population in the 1-10-year, 11-20-yea...
AbstractThe live oral poliovirus vaccine (OPV) strains are genetically unstable, causing, in rare ca...
The live oral poliovirus vaccine (OPV) strains are genetically unstable, causing, in rare cases, vac...
ABSTRACTThis study assessed immunity to poliomyelitis in a representative sample of 1064 persons liv...
During clinical trials, samples from Hungarian patients of different age groups were tested for anti...
The immune status against polioviruses was investigated in a population of 545 students aged 11-20 y...
In this study, the immunity level of the southern Greek population in the 1-10-year, 11-20-year, 21-...
Background: In October 2007, the working group CEN/TC 216 of the European Committee for standardisat...
The widespread use of poliovirus vaccination schemes has led to a marked decline in the incidence of...
The WHO European Region has been declared polio-free since 2002. By 2010, inactivated polio vaccine ...
Background and aim of the work: Recent seroprevalence studies in different population groups have ...
In 2002, the WHO European Region was declared polio-free. Nonetheless global eradication has not yet...
BACKGROUND: In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by rout...
Introduction. Italy and Europe were declared polio-free in June 2002, but increasing migration, even...
Abstract Introduction The extensive use of oral and inactivated poliovirus (PV) vaccines has driven ...